These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Hydrothorax in absence of ascites: an unusual complication of hepatic cirrhosis with portal hypertension]. Rombolà F; Spinoso A; Ranieri FS; Bertuccio A; Del Giudice AC; Bertuccio SN Clin Ter; 2005; 156(4):179-81. PubMed ID: 16342519 [TBL] [Abstract][Full Text] [Related]
7. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Siegerstetter V; Deibert P; Ochs A; Olschewski M; Blum HE; Rössle M Eur J Gastroenterol Hepatol; 2001 May; 13(5):529-34. PubMed ID: 11396532 [TBL] [Abstract][Full Text] [Related]
8. The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients. Wilputte JY; Goffette P; Zech F; Godoy-Gepert A; Geubel A Acta Gastroenterol Belg; 2007; 70(1):6-10. PubMed ID: 17619531 [TBL] [Abstract][Full Text] [Related]
9. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Gordon FD; Anastopoulos HT; Crenshaw W; Gilchrist B; McEniff N; Falchuk KR; LoCicero J; Lewis WD; Jenkins RL; Trey C Hepatology; 1997 Jun; 25(6):1366-9. PubMed ID: 9185754 [TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites. Andrade RJ; Martin-Palanca A; Fraile JM; Alcantara R; Carmona C; Medina MC; Muñoz V; Melgarejo F J Clin Gastroenterol; 1996 Jun; 22(4):305-7. PubMed ID: 8771428 [TBL] [Abstract][Full Text] [Related]
11. Refractory Hepatic Hydrothorax in the Absence of Ascites as a First Sign of Cirrhosis. Aloreidi K; Gedela M; Wabwire G; Mothapothula UM; Jha L S D Med; 2018 Apr; 71(4):168-170. PubMed ID: 29996034 [TBL] [Abstract][Full Text] [Related]
12. [Hepatic hydrothorax: report of a series of 77 patients]. Porcel JM; Mas E; Reñé JM; Bielsa S Med Clin (Barc); 2013 Dec; 141(11):484-6. PubMed ID: 24018252 [TBL] [Abstract][Full Text] [Related]
13. [Portal vein thrombosis after occlusion of a transjugular intrahepatic portosystemic stent-shunt (TIPSS). Shunt dilatation with subsequent local and systemic thrombolysis]. Gabler R; Barnert J; Bohndorf K; Eberl T; Wienbeck M Dtsch Med Wochenschr; 1997 Feb; 122(7):188-92. PubMed ID: 9072489 [TBL] [Abstract][Full Text] [Related]
14. Pleural effusion in liver disease. Alonso JC Semin Respir Crit Care Med; 2010 Dec; 31(6):698-705. PubMed ID: 21213201 [TBL] [Abstract][Full Text] [Related]
15. Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature. Badillo R; Rockey DC Medicine (Baltimore); 2014 May; 93(3):135-142. PubMed ID: 24797168 [TBL] [Abstract][Full Text] [Related]
16. [A case of refractory hepatic hydrothorax that was not treated by transjugular intrahepatic portosystemic shunt]. Park HW; Huh W; Kim SJ; Shin WC; Choi WC; Lee JH Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):327-30. PubMed ID: 12499792 [TBL] [Abstract][Full Text] [Related]